0001415889-21-002268.txt : 20210504
0001415889-21-002268.hdr.sgml : 20210504
20210504190745
ACCESSION NUMBER: 0001415889-21-002268
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210430
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watkin Jared
CENTRAL INDEX KEY: 0001645118
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 21890477
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-05042021_040530.xml
X0306
4
2021-04-30
0000001800
ABBOTT LABORATORIES
ABT
0001645118
Watkin Jared
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
SENIOR VICE PRESIDENT
Common shares without par value
2021-04-30
4
S
0
9533
120.016
D
59783
D
Common shares without par value
2021-04-30
4
M
0
17043
44.40
A
76826
D
Common shares without par value
2021-04-30
4
M
0
68000
59.94
A
144826
D
Common shares without par value
2021-04-30
4
S
0
85043
119.8879
D
59783
D
Common shares without par value
602
I
Profit Sharing Trust
Option (right to buy)
44.40
2021-04-30
4
M
0
17043
0
D
2018-02-17
2027-02-16
Common Shares
17043
0
D
Option (right to buy
59.94
2021-04-30
4
M
0
68000
0
D
2019-02-16
2028-02-15
Common Shares
68000
33987
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.0103 to $120.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.13, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2021.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
/s/ Jared Watkin by Jessica H. Paik, Attorney-in-Fact
2021-05-04